SIMPLEX QUANTUM Expands into Asia with Patent in India and Strategic Healthcare Initiative in Indonesia

Two Milestones Help Advance Heart Health Diagnostics Worldwide

(TOKYO, JAPAN) Simplex Quantum Inc., a developer of AI-powered healthcare solutions, proudly announces two key milestones in advancing heart health diagnostics globally. The company has secured a patent in India for its AI-based heart failure risk assessment technology and participated in the SMEDO initiative to better understand the healthcare needs in Indonesia.

Patent Success in India

Simplex Quantum's technology, co-developed with the University of Tokyo Hospital, leverages AI to analyze electrocardiogram (ECG) data, providing accessible and precise risk stratification of heart failure. This innovation is designed to reduce diagnostic burdens and empower timely intervention.

“The recent patent in India (No. 555582) is a significant addition to Simplex Quantum’s growing intellectual property portfolio, which already includes patents in Japan and the United States,” said CEO Ryu Saito. “With one of the largest populations globally, spread across diverse and often remote regions, India presents a critical opportunity to address healthcare access challenges with scalable and cost-effective solutions.”

Strategic Initiative in Indonesia

As part of its strategic expansion into Asia, Simplex Quantum participated in the SMEDO (Supporting Business Plan of Medical Equipment Development for Overseas) project which helps SMEs in Tokyo explore opportunities for medical devices in emerging countries. During this initiative, Simplex Quantum conducted site visits and engaged with local healthcare professionals in Indonesia to better understand the region’s unique medical needs.

“Insights from Indonesia are invaluable in addressing diagnostic accessibility gaps and advancing scalable, cost-effective healthcare solutions,” remarked Saito.

To learn more, visit: https://smedo.metro.tokyo.lg.jp/english.html

About SIMPLEX QUANTUM, Inc.

Founded in 2014, SIMPLEX QUANTUM develops technology in collaboration with partners including the University of Tokyo Hospital and Japan's Agency for Medical Research and Development. For more information, please visit https://simplex-q.com/en/